The Frequency of Tuberculosis in Adult Allogeneic Stem Cell Transplant Recipients in Turkey

Biology of Blood and Marrow Transplantation

Volumn 6, Issue 4, 2000, Pages 370-374

  Budak Alpdogan, Tulin ^a,c   Tangün, Yucel ^a   Kalayoglu Besisik, Sevgi ^a   Ratip, Siret ^b   Akan, Hamdi ^b   Baslar, Zafer ^b   Soysal, Teoman ^b   Bayik, Mahmut ^b   Koç, Haluk ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (United States)

Author keywords

Allogeneic; Mycobacteria; Stem cell transplantation; Tuberculosis

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER DISEASE; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY; SURVIVAL RATE; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISONIAZID; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LIVER DISEASES; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TUBERCULOSIS, PULMONARY; TURKEY;

EID: 0033642592     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(00)70013-9     Document Type: Article

References (22)

1. Aguado JM, Herrero JA, Gavalda J. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish transplantation infection study group, GESITRA. Transplantation. 1997;63:1278-1286.
2. Navari RM, Sullivan KM, Springmeyer SC. Mycobacterial infections in marrow transplant patients. Transplantation. 1983; 36:509-513.
3. Kurzrock R, Zander A, Vellekoop L, Kanojia M, Luna M, Dicke K. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med. 1984;77:35-40.
4. Rouleau M, Senik A, Leroy E, Vernant J-P. Long-term persistence of transferred PPD-reactive T cells after allogeneic bone marrow transplantation. Transplantation. 1993;55:72-76.
5. Hoyle C, Goldman JM. Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams. Bone Marrow Transplant. 1994;14:247-252.
6. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant. 1997;19:467-470.
7. Martino R, Martinez C, Brunet S, Sureda A, Lopez R, Domingo-Albos A. Tuberculosis in bone marrow recipients: report of two cases and review of the literature. Bone Marrow Transplant. 1996; 18:809-812.
8. Arslan Ö, Gürman G, Dilek I. Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey. Haematologia. 1998;29:59-62.
9. Kiliç B, Hamzaoglu O, eds. Tuberculosis statistics of Turkey. In: Health Statistics of Turkey. Ankara, Turkey: Turkish Medical Association; 1997:50.
10. Przepiorka D, Weisdorf D, Martin P. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-828.
11. Shulman HM, Sullivan KM, Weiden PL. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
12. McDonald GB, Hinds MS, Fisher LD. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993; 188:255-267.
13. Howard TP, Solomon DA. Reading the tuberculin skin test? Who, when, and how? Arch Intern Med. 1988;148:2457-2459.
14. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood. 1987;69:369-380.
15. Atkinson K. Reconstitution of the haematopoietic and immune system after marrow transplantation. Bone Marrow Transplant. 1990;5:209-226.
16. Jereb JA, Kelly GD, Dooley SW Jr, Cauthen GM, Snider DE Jr. Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ. 1991;40:23-27.
17. Daniel TM, Debanne SM. Estimation of the annual risk of tuberculosis infection for white men in the United States. J Infect Dis. 1997;175:1535-1537.
18. Gutierrez MC, Vincent V, Aubert D. Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area. J Clin Microbiol. 1998;36:486-492.
19. Bakhshi SS, Hawker J, Ali S. The epidemiology of tuberculosis by ethnic group in Birmingham and its implications for future trends in tuberculosis in the UK. Ethn Health. 1997;2:147-153.
20. Garcia Ordonez MA, Colmenero JD, Valencia A. Incidence and current clinical spectrum of tuberculosis in a metropolitan area in the south of Spain. Med Clin. 1998;110:51-55.
21. Passannante MR, Restifo RA, Reichman LB. Preventive therapy for the patient with both universal indication and contraindication for isoniazid. Chest. 1993;103:825-831.
22. Antony SJ, Ynares C, Dummer JS. Isoniazid hepatotoxicity in renal transplant recipients. Clin Transplant. 1997;11:34-37.